US Stock MarketDetailed Quotes
FMS Fresenius Medical Care
- 19.480
- -0.150-0.76%
Trading Jul 31 15:10 ET
11.43BMarket Cap21.81P/E (TTM)
19.550High19.370Low753.06KVolume19.390Open19.630Pre Close14.65MTurnover0.19%Turnover Ratio21.20P/E (Static)586.83MShares25.75852wk High0.78P/B7.75BFloat Cap15.90052wk Low0.64Dividend TTM397.83MShs Float51.648Historical High3.26%Div YieldTTM0.92%Amplitude0.515Historical Low19.452Avg Price1Lot Size
Fresenius Medical Care Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.22%4.77B | 0.44%4.72B | 0.29%19.45B | -0.18%4.99B | -3.14%4.94B | 1.44%4.83B | 3.42%4.7B | 10.10%19.4B | 7.53%5B | 14.74%5.1B |
| Operating revenue | -1.22%4.77B | 0.44%4.72B | 0.29%19.45B | -0.18%4.99B | -3.14%4.94B | 1.44%4.83B | 3.42%4.7B | 10.10%19.4B | 7.53%5B | 14.74%5.1B |
| Cost of revenue | -0.77%3.6B | -0.12%3.55B | 0.17%14.53B | -3.39%3.64B | -3.77%3.71B | 3.33%3.63B | 5.35%3.56B | 12.91%14.5B | 3.69%3.77B | 21.38%3.85B |
| Gross profit | -2.59%1.17B | 2.15%1.17B | 0.64%4.93B | 9.66%1.35B | -1.17%1.23B | -3.90%1.2B | -2.12%1.15B | 2.53%4.89B | 21.24%1.23B | -1.87%1.24B |
| Operating expense | -12.84%774M | -11.34%812.17M | 0.27%3.45B | -3.43%716.38M | -0.92%927.4M | 6.74%888M | 8.45%916M | 18.04%3.44B | 52.16%741.86M | 19.45%936M |
| Selling and administrative expenses | -0.52%771M | -0.81%775.64M | 0.82%3.2B | 4.95%845.16M | -2.86%793.79M | 2.25%775M | -1.01%782M | 14.34%3.17B | 61.08%805.27M | 11.75%817.18M |
| -Selling and marketing expense | ---- | --190.56M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | ---- | --585.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Research and development costs | -19.30%46M | -14.64%47.8M | 1.46%231.97M | 6.34%65.99M | -13.73%53.04M | 2.85%57M | 12.74%56M | 3.55%228.62M | -8.43%62.05M | 17.42%61.48M |
| Other operating expenses | -176.79%-43M | -114.46%-11.28M | -49.81%20.06M | -55.24%-194.76M | 40.53%80.57M | 202.15%56M | 1,460.94%78M | 149.88%39.96M | ---125.46M | --57.34M |
| Operating profit | 26.86%392M | 55.14%361.48M | 1.51%1.48B | 29.53%633.27M | -1.92%301.59M | -25.30%309M | -29.22%233M | -21.77%1.45B | -7.33%488.91M | -36.42%307.5M |
| Net non-operating interest income expense | -4.94%-85M | -6.25%-88.19M | -15.03%-336.42M | -12.32%-84.59M | -15.99%-88.72M | -13.16%-81M | -20.12%-83M | -4.30%-292.48M | -12.90%-75.32M | -11.76%-76.49M |
| Non-operating interest income | -25.00%18M | 30.53%15.66M | 30.38%88.22M | 8.53%26.87M | 56.64%25.14M | 88.28%24M | -14.97%12M | -7.53%67.66M | -12.71%24.75M | 2.95%16.05M |
| Non-operating interest expense | -1.90%103M | 9.32%103.85M | 17.91%424.64M | 11.38%111.46M | 23.04%113.86M | 24.52%105M | 14.17%95M | 1.85%360.14M | 5.26%100.07M | 10.13%92.54M |
| Other net income (expense) | -31.25%33M | -512.39%-115.47M | -288.01%-107.21M | -50.11%-205.63M | -86.21%22.64M | 165.61%48M | 51.70%28M | 888.02%57.02M | -74.61%-136.98M | 680.31%164.15M |
| Gain on sale of security | ---- | --6.46M | 85.14%-20.83M | ---- | ---- | ---- | ---- | -43.73%-140.18M | ---- | ---- |
| Earnings from equity interest | -31.25%33M | 3.01%28.84M | -43.29%121.79M | 12.55%23.37M | -86.21%22.64M | 147.84%48M | 167.00%28M | 132.99%214.76M | -0.96%20.76M | 680.31%164.15M |
| Special income (charges) | ---- | ---150.77M | -1,085.38%-208.16M | ---- | ---- | ---- | ---- | -833.10%-17.56M | ---- | ---- |
| -Gain on sale of business | ---- | ---151.85M | -229.04%-213M | ---- | ---- | ---- | ---- | -1,059.59%-64.73M | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | --1.08M | -89.74%4.84M | ---- | ---- | ---- | ---- | 646.74%47.17M | ---- | ---- |
| Income before tax | 23.19%340M | -11.33%157.83M | -15.28%1.03B | 24.02%343.06M | -40.40%235.51M | 2.63%276M | -36.10%178M | -22.43%1.22B | -27.67%276.62M | -9.41%395.16M |
| Income tax | 22.22%99M | -12.20%39.51M | -7.51%300.56M | 4.12%86.46M | -21.19%88.45M | 28.72%81M | -32.60%45M | -7.90%324.95M | 5.51%83.04M | 6.89%112.23M |
| Net income | 23.59%241M | -11.04%118.32M | -18.10%732.46M | 32.55%256.6M | -48.02%147.06M | -5.34%195M | -37.21%133M | -26.64%894.33M | -36.27%193.58M | -14.58%282.93M |
| Net income continuous Operations | 23.59%241M | -11.04%118.32M | -18.10%732.46M | 32.55%256.6M | -48.02%147.06M | -5.34%195M | -37.21%133M | -26.64%894.33M | -36.27%193.58M | -14.58%282.93M |
| Minority interest income | -1.82%54M | 0.76%47.36M | 5.68%233.46M | 25.37%68.67M | 18.70%62.71M | -6.57%55M | -13.67%47M | -11.53%220.92M | -26.96%54.78M | -9.21%52.83M |
| Net income attributable to the parent company | 33.57%187M | -17.49%70.96M | -25.90%499M | 35.39%187.93M | -63.34%84.35M | -4.85%140M | -45.35%86M | -30.53%673.41M | -39.32%138.8M | -15.73%230.1M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 33.57%187M | -17.49%70.96M | -25.90%499M | 35.39%187.93M | -63.34%84.35M | -4.85%140M | -45.35%86M | -30.53%673.41M | -39.32%138.8M | -15.73%230.1M |
| Basic earnings per share | 33.33%0.32 | -17.24%0.12 | -26.09%0.85 | 36.17%0.32 | -62.82%0.145 | -4.00%0.24 | -46.30%0.145 | -30.51%1.15 | -39.74%0.235 | -16.13%0.39 |
| Diluted earnings per share | 33.33%0.32 | -17.24%0.12 | -26.09%0.85 | 36.17%0.32 | -62.82%0.145 | -4.00%0.24 | -46.30%0.145 | -30.51%1.15 | -39.74%0.235 | -16.13%0.39 |
| Dividend per share | 0.5935 | 0 | 0 | 0 | 0 | 0 | 0 | -2.15%0.6577 | 0 | 0 |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg